Mid-HDF Randomized Controlled Study on Outcome

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 500 participants.

Also called NCT01693354

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 500 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01693354
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, France, Italy, Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01693354. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mid-HDF Randomized Controlled Study on Outcome
Acronym
MILESTONE
Condition
End Stage Renal Disease
Intervention (Device)
Mid-dilution HDF
Intervention (Device)
HF dialysis
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna (class: other)

Record details

Record id
cardio:ct-nct01693354
Content hash
fe9010fe343b0b8c53e872805770424b64abc6de487503f5e2a53fe0cbccadef